{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T17:12:14Z","timestamp":1743009134221,"version":"3.40.3"},"publisher-location":"Cham","reference-count":9,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030549169"},{"type":"electronic","value":"9783030549176"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/5584_2020_540","type":"book-chapter","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T07:02:30Z","timestamp":1589785350000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Data Analysis of Infection Rates Among Exposed Healthcare Workers Could Reveal Effective Prophylactics Against SARS-CoV-2"],"prefix":"10.1007","author":[{"given":"Guido","family":"N\u00fa\u00f1ez-Mujica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese","family":"Kichuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar","family":"Carrasco-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"issue":"12","key":"540_CR1","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","volume":"212","author":"J Chan","year":"2015","unstructured":"Chan J, Yao Y, Yeung ML, Deng W, Bao L, Jia L, Li F, Xiao C, Gao H, Yu P, Cai JP, Chu H, Zhou J, Chen H, Qin C, Yuen K (2015) Treatment with Lopinavir\/ritonavir or interferon-\u03b21b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J Infect Dis 212(12):1904\u20131913. \nhttps:\/\/doi.org\/10.1093\/infdis\/jiv392","journal-title":"J Infect Dis"},{"issue":"3","key":"540_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/thorax.2003.012658","volume":"59","author":"C Chu","year":"2004","unstructured":"Chu C, Cheng V, Hung I, Wong M, Chan K, Chan KS, Kao R, Poon L, Wong C, Guan Y, Peiris J, Yuen K (2004) Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 59(3):252\u2013256. \nhttps:\/\/doi.org\/10.1136\/thorax.2003.012658","journal-title":"Thorax"},{"key":"540_CR3","doi-asserted-by":"publisher","unstructured":"Cornwall W (2020) Can you put a price on COVID-19 options? Experts weigh lives versus economics. Science. \nhttps:\/\/doi.org\/10.1126\/science.abb9969","DOI":"10.1126\/science.abb9969"},{"key":"540_CR4","doi-asserted-by":"publisher","unstructured":"Ji T, Chen H, Xu J, Wu L, Li J, Chen K, Qin G (2020) Lockdown contained the spread of 2019 novel coronavirus disease in Huangshi city, China: early epidemiological findings. Clin Infect Dis. \nhttps:\/\/doi.org\/10.1093\/cid\/ciaa390","DOI":"10.1093\/cid\/ciaa390"},{"key":"540_CR5","doi-asserted-by":"publisher","unstructured":"Joob B, Wiwanitkit V (2020) SARS-CoV-2 and HIV. J Med Virol. \nhttps:\/\/doi.org\/10.1002\/jmv.25782\n\n. [Epub ahead of print]","DOI":"10.1002\/jmv.25782"},{"key":"540_CR6","doi-asserted-by":"publisher","unstructured":"Lippi G, Henry B, Bovo C, Sanchis-Gomar F (2020) Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosi. \nhttps:\/\/doi.org\/10.1515\/dx-2020-0041","DOI":"10.1515\/dx-2020-0041"},{"key":"540_CR7","unstructured":"U. S. National Library of Medicine, Clinical Trials System (2020a) Hydroxychloroquine vs. azithromycin for hospitalized patients with suspected or confirmed COVID-19 (HAHPS) NCT04329832. Created on 04\/04\/2020, Accessed on 16 Apr 2020. \nhttps:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04329832"},{"key":"540_CR8","unstructured":"U. S. National Library of Medicine, Clinical Trials System (2020b) Clinical study to evaluate the performance and safety of Favipiravir in COVID-19 NCT04336904. Created on 04\/04\/2020, Accessed on 16 Apr 2020. \nhttps:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04336904"},{"key":"540_CR9","unstructured":"U. S. National Library of Medicine, Clinical Trials System (2020c) Treatment of COVID-19 cases and chemoprophylaxis of contacts as prevention (HCQ4COV19) NCT04304053. Created on 07\/04\/2020, Accessed on 16 Apr 2020. \nhttps:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04304053"}],"container-title":["Advances in Experimental Medicine and Biology","Cell Biology and Translational Medicine, Volume 9"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2020_540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T14:13:05Z","timestamp":1598537585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/5584_2020_540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030549169","9783030549176"],"references-count":9,"URL":"https:\/\/doi.org\/10.1007\/5584_2020_540","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"19 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}